In which anatomical space is a cervical epidural injection placed for cervical spine pathology?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cervical Epidural Injection Placement

For cervical spine pathology, epidural injections are placed in the epidural space, most commonly accessed at the C6-C7 or C7-T1 interlaminar levels via a midline approach. 1

Anatomical Target Space

The epidural space is the target anatomical compartment for cervical epidural injections. This space lies between the ligamentum flavum and the dura mater, containing fat, blood vessels, and nerve roots as they exit the spinal canal 2.

Specific Access Levels and Approach

Preferred Interlaminar Levels

  • C6-C7 and C7-T1 are the standard and safest access points for cervical interlaminar epidural injections 1
  • These lower cervical levels provide increased epidural space compared to higher cervical levels, reducing risk of spinal cord injury
  • The midline interlaminar approach at these levels consistently provides bilateral coverage of the entire dorsal cervical epidural space 1

Coverage and Spread Patterns

Research demonstrates that contrast injected at C6-C7 spreads an average of 3.61 ± 0.84 vertebral levels, while C7-T1 spreads 3.88 ± 1.01 levels 1. Critically, this spread occurs consistently throughout the dorsal cervical epidural space regardless of injection volume or neck flexion angle 1, questioning the need for more dangerous higher-level injections.

Alternative Approaches

Transforaminal Approach

When targeting specific nerve roots, a transforaminal approach through the intervertebral foramen can be used 3, 4. However, this carries higher vascular risk due to the presence of segmental spinal arteries, which are located predominantly in the antero-superior quadrant (82% of cases) and postero-superior quadrant (18%) of the cervical intervertebral foramina 4.

Transarticular Approach

A transarticular approach through the facet joint represents an alternative when conventional epidural access is contraindicated, though this is less commonly performed 5.

Critical Safety Considerations

Depth Estimation

The depth from skin to epidural space at C7-T1 correlates with body mass index, weight, and neck circumference (r values 0.61-0.66), but individual predictions can be inaccurate by up to 1.6-1.7 cm 6. This unpredictability mandates careful technique.

Image Guidance Requirements

Fluoroscopic or ultrasound guidance with contrast confirmation is essential for cervical epidural injections 3. The narrow cervical epidural space (3-12 mm from skin to epidural space) 7 makes blind techniques unacceptably dangerous.

Pattern Recognition

Practitioners must distinguish true epidural spread from off-target patterns including intravascular, intrathecal, subdural, and fascial/retrodural flow 3. Intrathecal injection of an epidural dose would produce an unexpectedly high and dense neuraxial block 8.

Common Pitfalls

  • Avoid higher cervical levels (above C6) unless absolutely necessary—the decreased epidural space increases spinal cord injury risk
  • Never rely on external body measurements alone to predict epidural depth; always use image guidance
  • For transforaminal injections, target the postero-inferior quadrant of the intervertebral foramen to avoid the segmental spinal artery 4
  • Ultrasound-guided techniques using the "triple bar sign" (interspinal ligament, ligamentum flavum, and dura mater) can provide direct visualization and may enable safer outpatient procedures 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.